Akeso (STU:4RY) Net Interest Margin (Bank Only) %


STU:4RY Akeso Inc STU:4RY
56 GF Score
Price €10.54
GF Value €14.85
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Akeso Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:4RY
56GF Score
Akeso Inc STU:4RY
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Akeso (STU:4RY) Overvalued in 2026?

Based on GuruFocus' analysis, Akeso stock appears to be undervalued. The current stock price of €10.54 is trading 29.1% below its estimated GF Value™ of €14.85. GuruFocus considers Akeso to be Modestly Undervalued.

Key valuation signals for STU:4RY:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €14.85 vs. price of €10.54 (29.1% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the STU:4RY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Akeso Business Description

Other Exchanges AKESF:USA09926:Hong Kong
Address No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company has developed more than 50 drug candidates, including 15 bispecific antibody/multispecific antibody/bispecific antibody ADC/ADC/TCE drugs, with 27 drugs in clinical development. The majority of the company's revenue is derived from Mainland China, and it also has its presence in the USA and Other regions.
56GF Score

Get the complete analysis for STU:4RY

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.54
Price
€14.85
GF Value